Cubist Systematic Strategies’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$4.04M	Buy	+44,138	New	+$3.6M	0.02%	1095
2024 Q2	–	Sell	-55,683	Closed	-$3.85M	–	2934
2024 Q1	$3.85M	Buy	55,683 +21,939	+65%	+$1.32M	0.02%	1145
2023 Q4	$1.86M	Buy	33,744 +5,160	+18%	+$284K	0.01%	1574
2023 Q3	$1.66M	Buy	28,584 +25,114	+724%	+$1.45M	0.01%	1500
2023 Q2	$187K	Sell	3,470 -3,465	-50%	-$154K	﹤0.01%	2843
2023 Q1	$275K	Buy	+6,935	New	+$292K	﹤0.01%	3048
2022 Q4	–	Sell	-8,751	Closed	-$281K	–	4218
2022 Q3	$281K	Buy	+8,751	New	+$300K	﹤0.01%	3557
2022 Q1	–	Sell	-25,869	Closed	-$1.19M	–	3537
2021 Q4	$1.19M	Buy	+25,869	New	+$1.11M	0.01%	1787
2020 Q3	–	Sell	-12,499	Closed	-$404K	–	2476
2020 Q2	$404K	Buy	+12,499	New	+$448K	0.01%	1700
2020 Q1	–	Sell	-6,105	Closed	-$376K	–	2147
2019 Q4	$376K	Sell	6,105 -1,719	-22%	-$114K	0.01%	1710
2019 Q3	$570K	Buy	+7,824	New	+$585K	0.01%	1235
2019 Q1	–	Sell	-7,805	Closed	-$351K	–	2227
2018 Q4	$351K	Buy	+7,805	New	+$409K	0.02%	1171
2018 Q2	–	Sell	-18,027	Closed	-$1.05M	–	1771
2018 Q1	$1.05M	Buy	+18,027	New	+$1.14M	0.06%	413
2016 Q1	–	Sell	-4,744	Closed	-$214K	–	1593
2015 Q4	$214K	Buy	+4,744	New	+$204K	0.01%	1316
2015 Q3	–	Sell	-17,100	Closed	-$1.06M	–	1853
2015 Q2	$1.06M	Buy	+17,100	New	+$1.02M	0.05%	532
2015 Q1	–	Sell	-3,651	Closed	-$206K	–	1876
2014 Q4	$206K	Buy	+3,651	New	+$161K	0.01%	1493